作者:
Cameron, A. [1]
;
Chisholm, J. [2]
;
Elze, M. [3]
;
Casanova, M. [4]
;
Geoerger, B. [5]
;
Gaze, M. [6]
;
Oberlin, O. [7]
;
Bachir, J. [8]
;
Furst-Recktenwald, S. ;
Merks, J. H. M.
作者单位:
F Hoffmann La Roche Ltd, Pediat Oncol, Basel, Switzerland
[1]
Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol, Avon, England
[2]
Royal Marsden NHS Fdn Trust, Children & Young Peoples Unit, Sutton, Surrey, England
[3]
Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France
[4]
Fdn IRCCS Ist Nazl Tumori, Pediat Oncol Unit, Milan, Italy
[5]
Acad Med Ctr EKZ AMC, Emma Childrens Hosp, Dept Pediat Oncol, Amsterdam, Netherlands
[6]
Univ Coll London Hosp NHS Fdn Trust, Dept Oncol, London, England
[7]
F Hoffmann La Roche Ltd, Innovat Pediat Oncol Drug Dev, Basel, Switzerland
[8]
发布时间
2020-08-22